Ethnic differences in the comparative effectiveness of second‐line type 2 diabetes medications in preventing cardiovascular disease
We found weak evidence suggesting a greater effect of DPP4i than SUs against MACE in Black people, particularly for heart failure hospitalisation, but no evidence of other ethnic differences in treatment effects.
Authors
- Charlotte Warren‐Gash (ORCID: https://orcid.org/0000-0003-4524-3180)
- Rohini Mathur (ORCID: https://orcid.org/0000-0002-3817-8790)
- Christopher T. Rentsch (ORCID: https://orcid.org/0000-0002-1408-7907)
- Marleen Bokern
- Patrick Bidulka (ORCID: https://orcid.org/0000-0001-7644-2030)
- Mia Harley
- Anoop Shah (ORCID: https://orcid.org/0000-0002-2825-3419)
- Elizabeth Williamson (ORCID: https://orcid.org/0000-0001-6905-876X)
Institutions
- Queen Mary University of London (GB)
- Yale University (US)
- London School of Hygiene & Tropical Medicine (GB)
- Faculty of Public Health (GB)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-11-12
- DOI
- https://doi.org/10.1111/dom.70273
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00